QPS Missouri, the Springfield operation of Newark, Delaware-based clinical research organization QPS Holdings LLC, has expanded its Queen City campus.
A 2,750-square-foot expansion at the 1820 W. Mount Vernon St. facility added a new clinical safety laboratory, dedicated space to build and ship clinical trial kits, and updates to its self-contained pharmacy, according to a news release.
Trent Chance, senior marketing coordinator for QPS Missouri, said via email the lab became operational in November. Chance declined to disclose the company's financial investment in the expansion.
“QPS Missouri continues to expand and offer new services in Springfield, and the addition of a safety lab, the updated pharmacy and the clinical trial kit production area were the next steps to enhance our capabilities to provide comprehensive clinical trial services to the local Springfield community," said Brendon Bourg, QPS Missouri vice president, in the release. “Adding this new safety lab to our local clinical trial facility means that our physicians can receive laboratory results in real time, adding an additional level of safety for participants. In addition, QPS can now offer these new clinical trial capabilities to our valued clients.”
QPS Missouri has been conducting clinical research studies for around 30 years, with assistance from more than 50,000 study participants, according to past reporting. The company's website indicates that QPS has conducted more than 1,500 FDA-regulated studies and paid out nearly $50 million to participants since opening in Springfield in 1994.
SBJ interviews the associate dean, vice chair and professor of the University of Missouri-Kansas City School of Pharmacy at Missouri State University.